Christopher Rohde discuss the use of stimulants in patients with schizophrenia. In a register-based study the authors found that patients with schizophrenia treated with CNS stimulants has a reduced risk of psychiatric admission, fewer days per admission and lower use of antipsychotic medication. Read more here (in Danish).